Molecular characteristics of pharyngeal and invasive emm3 Streptococcus pyogenes strains from Norway, 1988–2003

Meisal, R.; Høiby, E.; Caugant, D.; Musser, J.
January 2010
European Journal of Clinical Microbiology & Infectious Diseases;Jan2010, Vol. 29 Issue 1, p31
Academic Journal
A major virulence factor of group A streptococci (GAS) is the M protein. Strains with the M3 type are more often associated with necrotizing fasciitis (NF) and streptococcal toxic shock syndrome, and have a higher case fatality rate than strains of other M types. To better understand the epidemiology of M3 GAS strains in Norway, we analyzed 59 invasive and 69 pharyngeal isolates with respect to prophage content, allelic variation in emm3, mtsR encoding the metal transporter of Streptococcus repressor ( mtsR), and sclB coding for streptococcal collagen-like protein B. The Norwegian emm3 strains were very homogeneous, mainly harboring the emm allele 3.1 and prophage profile ΦG3.01. Other prophage profiles were transient. The mutation in mtsR known to truncate the protein and result in decreased capacity to cause NF was not found in our isolates. The sclB gene usually harbored five or eight contiguous repeats of a CAAAA pentanucleotide sequence and a highly modular and variable collagen structural motif (CSM) region with 9 and 12 amino acid M3-specific conserved motif repeats distributed across the entire CSM region. Strains with 5 CAAAA repeats emerged in 1993 and these strains were associated with the increase in invasive M3 cases in the period 1993–2003.


Related Articles

  • Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational Study. Linnér, Anna; Darenberg, Jessica; Sjölin, Jan; Henriques-Normark, Birgitta; Norrby-Teglund, Anna // Clinical Infectious Diseases;Sep2014, Vol. 59 Issue 6, p851 

    This study provides evidence for intravenous immunoglobulin as a safe adjunctive therapy that contributes to improved survival in streptococcal toxic shock syndrome. In addition, this study gives further clinical support for the use of clindamycin in these patients.Background. Streptococcal...

  • Protective Effect of Hainosankyuto, a Traditional Japanese Medicine, on Streptococcus pyogenes Infection in Murine Model. Minami, Masaaki; Ichikawa, Mariko; Hata, Nanako; Hasegawa, Tadao // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: Streptococcus pyogenes (S. pyogenes) causes various serious diseases including necrotizing fasciitis and streptococcal toxic shock syndrome. One serious problem observed recently with S. pyogenes therapy is attenuation of the antibiotic effect, especially penicillin treatment failure...

  • Development of a DNA aptamer that binds specifically to group A Streptococcus serotype M3. Alfavian, Hanif; Mousavi Gargari, Seyed Latif; Rasoulinejad, Samaneh; Medhat, Arvin // Canadian Journal of Microbiology;2017, Vol. 63 Issue 2, p160 

    Group A streptococcus (GAS) is an important Gram-positive pathogen that causes various human diseases ranging from peripheral lesions to invasive infections. The M protein is one of the main virulence factors present on the cell surface and is associated with invasive GAS infections. Compared...

  • Getting under the Skin: The Immunopathogenesis of Streptococcus pyogenes Deep Tissue Infections. Johansson, Linda; Thulin, Pontus; Low, Donald E.; Norrby-Teglund, Anna // Clinical Infectious Diseases;7/1/2010, Vol. 51 Issue 1, p58 

    Streptococcus pyogenes can cause a variety of diseases in immunocompetent individuals, from pharyngotonsillitis to life-threatening invasive diseases, such as streptococcal toxic shock syndrome, and rapidly progressing deep-tissue infections, such as necrotizing fasciitis. Necrotizing fasciitis...

  • Síndrome de choque tóxico secundario a fascitis necrosante por Streptococcus pyogenes: informe de un caso clínico. Cuellar, René Alfredo Bourlon; de los Ríos, María Teresa Bourlon; Nuche, Mariana López; de los Ríos, Christianne Bourlon; Urquiza, Rafael Vera; Camacho, José Luis; Acosta, Leticia Arcos // Medicina Interna de Mexico;jul/ago2010, Vol. 26 Issue 4, p397 

    No abstract available.

  • Invasive Group B Streptococcal Disease in Non-pregnant Adults. Sendi, P.; Johansson, L.; Norrby-Teglund, A. // Infection;Apr2008, Vol. 36 Issue 2, p100 

    Streptococcus agalactiae, commonly referred as group B Streptococcus (GBS), is a major cause of neonatal sepsis and infections in pregnant women. However, the number of invasive infections in non-pregnant adults is growing. Elderly patients and those with chronic underlying conditions, such as...

  • Necrotizing Fasciitis in a Pediatric Patient Caused by Lancefield Group G Streptococcus: Case Report and Brief Review of the Literature. Rausch, John; Foca, Marc // Case Reports in Medicine;2011, p1 

    We report a case of necrotizing fasciitis with an accompanying toxic shock syndrome caused by Group G Streptococcus in a pediatric patient with a lymphatic malformation. Pediatricians need to be aware of the possibility of such infections, especially in those with vascular/lymphatic...

  • DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Walker, Mark J.; Hollands, Andrew; Sanderson-Smith, Martina L.; Cole, Jason N.; Kirk, Joshua K.; Henningham, Anna; McArthur, Jason D.; Dinkla, Katrin; Aziz, Ramy K.; Kansal, Rita G.; Simpson, Amelia J.; Buchanan, John T.; Chhatwal, Gursharan S.; Kotb, Malak; Nizet, Victor // Nature Medicine;Aug2007, Vol. 13 Issue 8, p981 

    Most invasive bacterial infections are caused by species that more commonly colonize the human host with minimal symptoms. Although phenotypic or genetic correlates underlying a bacterium's shift to enhanced virulence have been studied, the in vivo selection pressures governing such shifts are...

  • Invasive group A streptococcal infections. Weir, Erica; Main, Cheryl // CMAJ: Canadian Medical Association Journal;7/4/2006, Vol. 175 Issue 1, p32 

    Presents information on invasive group A streptococci (GAS) infection. Incidence of the infections in Canada in 2000; Features of necrotizing fasciitis; Diagnosis of toxic shock syndrome; Prevention of GAS infections.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics